Business Wire

Wemade’s MIR M Presents Evolved Tokenomics with WEMIX$ Payment

Share

Wemade's blockbuster MMORPG MIR M: Vanguard and Vagabond (hereinafter "MIR M") upgraded its tokenomics on April 18th.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230418005641/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

MIR M upgraded its tokenomics and expanded the inter-game economy through WEMIX ecosystem (Graphic: Wemade)

First, WEMIX$ Payment system has been implemented in MIR M. Users can purchase in-game products with cash (USD), or with pWEMIX$, which can be exchanged 1:1 with WEMIX$. And the inter-game economy has been expanded further with the addition of a new feature that allows users to Swap other Game Tokens from the WEMIX ecosystem with pWEMIX$ to make payments.

Party Dungeon Governance has also been added. Users wishing to participate in Party Dungeon content must stake DOGMA in the Governance Staking Pool for each character. Users who have Staked the minimum amount required or more will be able to create Parties for Party Dungeons. This addition has expanded the scope of Governance to include personalized content, and increased the utility of the Game Token, DOGMA.

Governance connected with the mining of Darksteel may increase the value of Darksteel, which can be mined in MIR M, as well as the Game Token, "DRONE." Darksteel mining rate will be reduced by 50% in Servers that have either failed to reach the rankings required to hold Hidden Valley Capture in Hidden Valley Capture Governance votes, or have not reached the minimum Staking requirements.

Spring events will also be held. With the "Spring 14 Days Check-in" event, users can obtain bountiful rewards such as "Companion Summoning Ticket," "Avatar Summoning Ticket," "Dungeon Raid Entry Ticket," and more until May 1st.

The event dungeon "Elite Sealed Tower" will also be available until the update on May 2nd. Users can gain more EXP than in the original "Sealed Tower," as well as a chance to obtain Relic gear. Entry will be limited to 1 hour each day for characters of level 20 or higher.

During the same period, users who have successfully cleared Party Dungeons will obtain "Party Dungeon Event Chest" as rewards, containing special items such as "Mandala Materials (Dragon Orbs or Phoenix Orbs)." Other improvements to make character growth easier include decreases in the costs and materials needed for Skill Tome Crafting, as well as discounts on coins needed for Mandala Enhancement.

More information on MIR M is available on the official website.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Wemade Co., Ltd. (112040: KOSDAQ)
Yeonghyun Lee, PR Manager
yeonghyun@wemade.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer26.4.2024 15:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of fruquintinib, a selective inhibitor of vascular endothelial growth factor receptors (VEGFR) -1, -2 and -3 for the treatment of adult patients with previously treated metastatic colorectal cancer (mCRC). The European Commission (EC) will consider the CHMP positive opinion when determining the potential marketing authorization for fruquintinib for mCRC throughout the European Union (EU), Norway, Liechtenstein and Iceland. If approved, fruquintinib will be the first and only selective inhibitor of all three VEGF receptors approved in the EU for previously treated mCRC.1,2 “People living with metastatic colorectal cancer in the European Union currently have limited treatment options, which can lead to poor outcomes. With this positive opinion for fruquintinib, we are one step closer to potentially offering patients a new

MEDIA ALERT: Wolters Kluwer expert comments on European Parliament vote to pass amendment implementing Basel III reforms26.4.2024 15:00:00 EEST | Press release

The European financial landscape saw a milestone event this week, as the EU Parliament passed the Amendment to Regulation (EU) No 575/2013, implementing the Basel III finalization within Europe. This monumental step forward comes with the adoption of the Capital Requirements Regulation (CRR3) amendments, which are part of a broader legislative package, including amendments to Directive 2013/36/EU, known as the Capital Requirements Directive or CRD. Jeroen Van Doorsselaere, Vice President of Global Product & Platform Management, Wolters Kluwer FRR, said: “The adoption of the Capital Requirements Regulation (CRR3) amendments represents a landmark change for the banking industry, designed to strengthen the framework for risk-based capital requirements and address ESG risks. “This is a major overhaul of the capital requirements framework, impacting various aspects, including credit risk, operational risk, market risk, and the capital floor. Whereas other significant jurisdictions, includin

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye